Why the study?
Hypothermia is used therapeutically and occurs accidentally, with ventricular arrhythmias causing high mortality, prompting a review of the effect of hypothermia on cardiac electrophysiology.
What is the effect of hypothermia on cardiac electrophysiology in clinical and experimental settings?
What is the effect of hypothermia on cardiac electrophysiology in clinical and experimental settings?
Hypothermia progressively alters cardiac electrophysiology, notably prolonging the QT interval and increasing the risk of severe ventricular arrhythmias, suggesting QT-prolonging drugs should be avoided.
Answers are grounded in this paper and cite their sources.
Severe hypothermia promotes ventricular arrhythmias; leaves open optimal temperature targets in therapeutic protocols.
Moderate therapeutic hypothermia procedures are used in post-cardiac arrest care, while in surgical procedures, lower core temperatures are often utilized to provide cerebral protection. Involuntary reduction of core body temperature takes place in accidental hypothermia and ventricular arrhythmias are recognized as a principal cause for a high mortality rate in these patients. We assessed both clinical and experimental literature through a systematic literature search in the PubMed database, to review the effect of hypothermia on cardiac electrophysiology. From included studies, there is common experimental and clinical evidence that progressive cooling will induce changes in cardiac electrophysiology. The QT interval is prolonged and appears more sensitive to decreases in temperature than the QRS interval. Severe hypothermia is associated with more pronounced changes, some of which are proarrhythmic. This is supported clinically where severe accidental hypothermia is commonly associated with ventricular fibrillation or asystole. J-waves in human electrocardiogram recordings are regularly but not always observed in hypothermia. Its relation to ventricular repolarization and arrhythmias is not obvious. Little clinical data exist on efficacy of anti-arrhythmic drugs in hypothermia, while experimental data show the potential of some agents, such as the class III antiarrhythmic bretylium. It is apparent that QT-prolonging drugs should be avoided.
No takes yet. Share an insight, caveat, or question.
Dietrichs et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: